According to our (Global Info Research) latest study, the global Moclobemide Tablet market size was valued at US$ 84.4 million in 2024 and is forecast to a readjusted size of USD 112 million by 2031 with a CAGR of 4.2% during review period.
Moclobemide is a monoamine oxidase (MAO) inhibitor used to treat certain types of mental depression. It works by blocking the action of a chemical substance known as monoamine oxidase (MAO) in the nervous system.
Moclobemide tablets, an antidepressant medication, hold a promising position in the market. With increasing global awareness of mental health issues and a growing number of individuals affected by depression, the sales of Moclobemide tablets are on the rise. Its unique mechanism of action has made it a preferred choice for the treatment of mild to moderate depression. In the future, as more clinical research and innovative drug combinations emerge, Moclobemide tablets are expected to maintain their significance in the global market.
This report is a detailed and comprehensive analysis for global Moclobemide Tablet market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Moclobemide Tablet market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Moclobemide Tablet market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Moclobemide Tablet market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Moclobemide Tablet market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Moclobemide Tablet
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Moclobemide Tablet market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Viatris, Apotex, Arrow Pharmaceuticals, Sandoz, Lunan Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Moclobemide Tablet market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
150mg
300mg
Market segment by Application
Hospital
Clinic
Other
Major players covered
Roche
Viatris
Apotex
Arrow Pharmaceuticals
Sandoz
Lunan Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Moclobemide Tablet product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Moclobemide Tablet, with price, sales quantity, revenue, and global market share of Moclobemide Tablet from 2020 to 2025.
Chapter 3, the Moclobemide Tablet competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Moclobemide Tablet breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Moclobemide Tablet market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Moclobemide Tablet.
Chapter 14 and 15, to describe Moclobemide Tablet sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Moclobemide Tablet. Industry analysis & Market Report on Moclobemide Tablet is a syndicated market report, published as Global Moclobemide Tablet Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Moclobemide Tablet market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.